Chemical Biology and Medicinal Chemistry
Seamlessly blending chemistry, biology and computational science to discover new therapeutic agents and targets
The Division of Chemical Biology and Medicinal Chemistry (CBMC) is engaged in the education and research of the principles of drug discovery with a focus on identifying new therapeutic agents and targets.
Our faculty is comprised of the creators of three FDA-approved drugs, NIH study section members, entrepreneurs, editorial board members, and authors of hundreds of scholarly works.
You can learn more about our faculty here.
CBMC is training the next generation of researchers specializing in drug discovery, and a clear strength is the cadre of young scientists comprising our graduate students and postdoctoral fellows.
You can learn more about our PhD in Pharmaceutical Sciences program here.
CBMC has research strengths in the synthesis and structure-activity characterization of pharmaceutically relevant small molecules and natural products; bioorganic and chemical biology studies of the properties of designed small-molecule ligands and their cognate drug targets, including proteins, nucleic acids, and glycoconjugates; combinatorial biochemistry and proteomics for the identification of novel signaling pathways and drug targets; structural biology and biomolecular dynamics of drug-protein interactions; chemo- and bioinformatics; and molecular modeling.
You can learn more about our current research and capabilities here.
You can learn more about our faculty labs here.
For general questions regarding the Phd program, write to email@example.com.